Skip to main content

Articles

Page 45 of 76

  1. The NSD family of histone lysine methyltransferases have emerged as important biomarkers that participate in a variety of malignancies. Recent evidence has indicated that somatic dysregulation of the nuclear r...

    Authors: Shuhua Zhang, Fan Zhang, Qing Chen, Chidan Wan, Jun Xiong and Jianqun Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:467
    Content type: Research Published on:

  2. The deubiquitinase USP7 has been identified as an oncogene with key roles in tumorigenesis and therapeutic resistance for a series of cancer types. Recently small molecular inhibitors have been developed to ta...

    Authors: Yuchong Peng, Youhong Liu, Yingxue Gao, Bowen Yuan, Xuli Qi, Yuxin Fu, Qianling Zhu, Tuoyu Cao, Songwei Zhang, Linglong Yin and Xiong Li
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:468
    Content type: Research Published on:

  3. The activation of tumour-associated macrophages (TAMs) contributes to the progression of hepatocellular carcinoma (HCC). SIRT4 acts as a tumour suppressor of tumour growth by regulating cell metabolism, inflam...

    Authors: Zhi Li, He Li, Zhi-Bo Zhao, Wei Zhu, Pan-Pan Feng, Xi-Wen Zhu and Jian-Ping Gong
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:469
    Content type: Research Published on:

  4. Accumulation evidence indicates the vital role of long non-coding RNAs (lncRNAs) in tumorigenesis and the progression of malignant tumors, including pancreatic cancer (PC). However, the role and the molecular ...

    Authors: Shan Lei, Zhiwei He, Tengxiang Chen, Xingjun Guo, Zhirui Zeng, Yiyi Shen and Jianxin Jiang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:470
    Content type: Research Published on:

  5. Adhesion molecules distributed on the cell-surface depends upon their dynamic trafficking that plays an important role during cancer progression. ADP-ribosylation factor 6 (Arf6) is a master regulator of membr...

    Authors: Shanshan Qi, Linjia Su, Jing Li, Chuanshan Zhang, Zhe Ma, Guiqiu Liu, Qing Zhang, Guhe Jia, Yongjun Piao and Sihe Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:471
    Content type: Research Published on:

  6. Alteration of signalling pathways regulating cell cycle progression is a common feature of cancer cells. Several drugs targeting distinct phases of the cell cycle have been developed but the inability of many ...

    Authors: Ouma Cisse, Muzthahid Quraishi, Federico Gulluni, Federica Guffanti, Ioanna Mavrommati, Methushaa Suthanthirakumaran, Lara C. R. Oh, Jessica N. Schlatter, Ambisha Sarvananthan, Massimo Broggini, Emilio Hirsch, Marco Falasca and Tania Maffucci
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:472
    Content type: Research Published on:

  7. Circulating tumour cells (CTCs), especially mesenchymal CTCs, are important determinants of metastasis, which leads to most recurrence and mortality in hepatocellular carcinoma (HCC). However, little is known ...

    Authors: Yujun Tang, Yishi Lu, Yuan Chen, Lei Luo, Lei Cai, Bangjian Peng, Wenbin Huang, Hangyu Liao, Liang Zhao and Mingxin Pan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:473
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2021 40:234

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:130

  8. The inflammatory cytokine interleukin-6 (IL-6) is critical for the expression of octamer-binding transcription factor 4 (OCT4), which is highly associated with early tumor recurrence and poor prognosis of hepa...

    Authors: Ssu-Chuan Lai, Yu-Ting Su, Ching-Chi Chi, Yung-Che Kuo, Kam-Fai Lee, Yu-Chih Wu, Pei-Chi Lan, Muh-Hwa Yang, Te-Sheng Chang and Yen-Hua Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:474
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:10

  9. Forkhead box G1 (FOXG1) is a member of the Fox transcription factor family involved in regulation of many cancers. However, the role of FOXG1 in hepatocellular carcinogenesisis largely unclear. The present stu...

    Authors: Xingrong Zheng, Jiaxin Lin, Hewei Wu, Zhishuo Mo, Yunwen Lian, Peipei Wang, Zhaoxia Hu, Zhiliang Gao, Liang Peng and Chan Xie
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:475
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2021 40:104

  10. Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer. The dismal outcome of ICC patients is due to lack of early diagnosis, the aggressive biological behavior of ICC and the lac...

    Authors: Jian-Hui Li, Xiao-Xu Zhu, Fu-Xi Li, Chen-Song Huang, Xi-Tai Huang, Jie-Qin Wang, Zhuo-Xing Gao, Shi-Jin Li, Qiong-Cong Xu, Wei Zhao and Xiao-Yu Yin
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:476
    Content type: Research Published on:

  11. In recent years, long non-coding RNAs (lncRNAs) are of great importance in development of different types of tumors, while the function of lncRNA ZFAS1 is rarely discussed in esophageal squamous cell carcinoma...

    Authors: Zhirong Li, Xuebo Qin, Wei Bian, Yishuai Li, Baoen Shan, Zhimeng Yao and Shujun Li
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:477
    Content type: Research Published on:

  12. KH-type splicing regulatory protein (KHSRP) plays an important role in cancer invasion, but the relevant mechanism is not well known. In the present study, we investigated the function and potential molecular ...

    Authors: Mingxia Yan, Lei Sun, Jing Li, Huajian Yu, Hechun Lin, Tao Yu, Fangyu Zhao, Miaoxin Zhu, Lei Liu, Qin Geng, Hanwei Kong, Hongyu Pan and Ming Yao
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:478
    Content type: Research Published on:

  13. Non small cell lung cancer (NSCLC) is one of the most common cancers in the world. DHA is known to be capable of suppressing NSCLC cell proliferation and metastasis. However, the mechanisms by which DHA exhibi...

    Authors: Xiaoming Bai, Jiaofang Shao, Sujin Zhou, Zhenggang Zhao, Fanghong Li, Rong Xiang, Allan Z. Zhao and Jinshun Pan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:479
    Content type: Research Published on:

  14. In the original publication of this article [1], Fig. 6 is wrong and the updated figure is shown below.

    Authors: Xiao-Ping Chen, Xin Long, Wen-long Jia, Han-Jie Wu, Jing Zhao, Hui-Fang Liang, Arian Laurence, Jun Zhu, Dong Dong, Yan Chen, Long Lin, Yu-Dong Xia, Wei-Yang Li, Gui-Bo Li, Zhi-Kun Zhao, Kui Wu…
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:480
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:261

  15. Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to lung adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors induces a cancer stem cell (CSC) phenotype. Her...

    Authors: Jiahui Si, Yuanyuan Ma, Ji Wang Bi, Ying Xiong, Chao Lv, Shaolei Li, Nan Wu and Yue Yang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:481
    Content type: Research Published on:

  16. Identification of novel cancer-associated splice variants is of potential diagnostic, prognostic and therapeutic importance. NF-Y transcription factor is comprised of NF-YA, NF-YB and NF-YC subunits, binds inv...

    Authors: Lucia Cappabianca, Antonietta Rosella Farina, Lucia Di Marcotullio, Paola Infante, Daniele De Simone, Michela Sebastiano and Andrew Reay Mackay
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:482
    Content type: Research Published on:

  17. The dysfunction of type I interferon (IFN) signaling is an important mechanism of immune escape and metastasis in tumors. Increased NOS1 expression has been detected in melanoma, which correlated with dysfunct...

    Authors: Pengfei Xu, Shuangyan Ye, Keyi Li, Mengqiu Huang, Qianli Wang, Sisi Zeng, Xi Chen, Wenwen Gao, Jianping Chen, Qianbing Zhang, Zhuo Zhong, Ying Lin, Zhili Rong, Yang Xu, Bingtao Hao, Anghui Peng…
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:483
    Content type: Research Published on:

  18. Protein tyrosine phosphatase receptor delta (PTPRD) is frequently inactivated in various types of cancers. Here, we explored the underlying mechanism of PTPRD-loss-induced cancer metastasis and investigated an...

    Authors: Won Jung Bae, Ji Mi Ahn, Hye Eun Byeon, Seokwhi Kim and Dakeun Lee
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:484
    Content type: Research Published on:

  19. Recent studies have reported that Integrin alpha 2 (ITGA2) plays an essential role in tumor cell proliferation, invasion, metastasis, and angiogenesis. An abnormally expressed ITGA2 correlates with unfavorable...

    Authors: Dianyun Ren, Jingyuan Zhao, Yan Sun, Dan Li, Zibo Meng, Bo Wang, Ping Fan, Zhiqiang Liu, Xin Jin and Heshui Wu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:485
    Content type: Research Published on:

  20. Gliomas are common life-threatening cancers, mainly due to their aggressive nature and frequent invasiveness and long non-coding RNAs (lncRNAs) are emerging as promising molecular targets. Therefore, we explor...

    Authors: Haiyang Xu, Guifang Zhao, Yu Zhang, Hong Jiang, Weiyao Wang, Donghai Zhao, Hongquan Yu and Ling Qi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:486
    Content type: Research Published on:

  21. Arsenic sulfide was found to have potential anti-cancer activities, especially in gastric cancer. However, the underlying mechanism need to be further explored. This study was aimed to investigate the mechanis...

    Authors: Ting Kang, Maolin Ge, Ruiheng Wang, Zhen Tan, Xiuli Zhang, Chuanying Zhu, Han Liu and Siyu Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:487
    Content type: Research Published on:

  22. Accumulating evidence indicates that aberrant microRNA (miRNA) expression contributes to osteosarcoma progression. This study aimed to elucidate the association between miR-624-5p expression and osteosarcoma (...

    Authors: Yongjun Luo, Wei Liu, Pengyu Tang, Dongdong Jiang, Changjiang Gu, Yumin Huang, Fangyi Gong, Yuluo Rong, Dingfei Qian, Jian Chen, Zheng Zhou, Shujie Zhao, Jiaxing Wang, Tao Xu, Yongzhong Wei, Guoyong Yin…
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:488
    Content type: Research Published on:

  23. Ischemia reperfusion injury (IRI) has been shown to increase the risk of tumor recurrence after liver surgery. Also, nonalcoholic fatty liver disease (NAFLD) is associated with increased HCC recurrence. ALOX12...

    Authors: Faji Yang, Yuheng Zhang, Haozhen Ren, Jinglin Wang, Longcheng Shang, Yang Liu, Wei Zhu and Xiaolei Shi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:489
    Content type: Research Published on:

  24. N-myc downstream-regulated gene 1 (NDRG1) has been shown to play a key role in tumor metastasis. Recent studies demonstrate that NDRG1 can suppress tumor growth and is related to tumor proliferation; however, ...

    Authors: Sen Zhang, Chaoran Yu, Xiao Yang, Hiju Hong, Jiaoyang Lu, Wenjun Hu, Xiaohui Hao, Shuchun Li, Batuer Aikemu, Guang Yang, Zirui He, Luyang Zhang, Pei Xue, Zhenghao Cai, Junjun Ma, Lu Zang…
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:490
    Content type: Research Published on:

  25. Growing evidence showed the increased prevalence of cancer incidents, particularly colorectal cancer, among type 2 diabetic mellitus patients. Antidiabetic medications such as, insulin, sulfonylureas, dipeptyl...

    Authors: Muhamad Noor Alfarizal Kamarudin, Md. Moklesur Rahman Sarker, Jin-Rong Zhou and Ishwar Parhar
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:491
    Content type: Review Published on:

  26. Molecular mechanisms driving acquired resistance to anti-EGFR therapies in metastatic colorectal cancer (mCRC) are complex but generally involve the activation of the downstream RAS-RAF-MEK-MAPK pathway. Never...

    Authors: S. Napolitano, N. Matrone, A. L. Muddassir, G. Martini, A. Sorokin, V. De Falco, E. F. Giunta, D. Ciardiello, E. Martinelli, V. Belli, M. Furia, S. Kopetz, F. Morgillo, F. Ciardiello and T. Troiani
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:492
    Content type: Research Published on:

  28. Downregulation of microRNA-338-3p (miR-338-3p) was detected in many malignant tumors, which indicated miR-338-3p might serve as a role of antioncogene in those cancers. The present study aimed to explore the r...

    Authors: Ruitao Zhang, Huirong Shi, Fang Ren, Wei Feng, Yuan Cao, Gailing Li, Zheying Liu, Pengcheng Ji and Minghui Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:494
    Content type: Research Published on:

  29. Human bone marrow mesenchymal stem cells (hBMSCs) are implicated in cancer initiation and metastasis, sometimes by releasing exosomes that mediate cell communication by delivering microRNAs (miRNAs). This stud...

    Authors: Shuangjian Jiang, Chengqiang Mo, Shengjie Guo, Jintao Zhuang, Bin Huang and Xiaopeng Mao
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:495
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2022 41:206

  30. In the original publication of this article [1], the images of Figs. 4 and 5 were exchanged and the legends of the two figures did not correspond due to a typesetting error.

    Authors: Mineko Terao, Laura Goracci, Valentina Celestini, Mami Kurosaki, Marco Bolis, Alessandra Di Veroli, Arianna Vallerga, Maddalena Fratelli, Monica Lupi, Alessandro Corbelli, Fabio Fiordaliso, Maurizio Gianni, Gabriela Paroni, Adriana Zanetti, Gabriele Cruciani and Enrico Garattini
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:496
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:436

  31. The survival of pancreatic cancer patients remains poor. However, the underlying molecular mechanism and new therapeutic target of pancreatic cancer are still needed to be found. Many studies have shown that t...

    Authors: Xiaodong Xu, Yan Yu, Ke Zong, Pengwei Lv and Yuantin Gu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:497
    Content type: Research Published on:

  32. The MYCN amplification is a defining hallmark of high-risk neuroblastoma. Due to irregular oncogenes orchestration, tumor cells exhibit distinct fatty acid metabolic features from non-tumor cells. However, the...

    Authors: Yi Ding, Jie Yang, Yawen Ma, Tengteng Yao, Xingyu Chen, Shengfang Ge, Lihua Wang and Xianqun Fan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:498
    Content type: Research Published on:

  33. Mortalin is enriched in a large variety of cancers and has been shown to contribute to proliferation and migration of cancer cells in multiple ways. It has been shown to bind to p53 protein in cell cytoplasm a...

    Authors: Jayarani F. Putri, Priyanshu Bhargava, Jaspreet Kaur Dhanjal, Tomoko Yaguchi, Durai Sundar, Sunil C. Kaul and Renu Wadhwa
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:499
    Content type: Research Published on:

  34. In the original publication of this article [1], the author found an error in Fig. 2f. lncGPR107 should be changed to lncMAPK6, and the corrected Fig. 2 is shown below.

    Authors: Guanqun Huang, Hui Jiang, Yueming He, Ye Lin, Wuzheng Xia, Yuanwei Luo, Min Liang, Boyun Shi, Xinke Zhou and Zhixiang Jian
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:500
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:105

  35. Esophageal cancer is one of the most common malignant tumors in the world. With currently available therapies, only 20% ~ 30% patients can survive this disease for more than 5 years. TRAIL, a natural ligand fo...

    Authors: Lujuan Han, Suli Dai, Zhirong Li, Cong Zhang, Sisi Wei, Ruinian Zhao, Hongtao Zhang, Lianmei Zhao and Baoen Shan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:501
    Content type: Research Published on:

  36. Gastric cancer (GC) is one of the most prevalent and deadly malignancies worldwide. Accumulating reports have indicated the participation of long non-coding RNAs (lncRNAs) in the onset and progression of GC.

    Authors: Yangyang Dong, Xinyu Li, Zhibin Lin, Wenbing Zou, Yan Liu, Huiyang Qian and Jing Jia
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:502
    Content type: Research Published on:

  37. The treatment of metastatic osteosarcoma (OS) remains a challenge for oncologists, and novel therapeutic strategies are urgently needed. An understanding of the pathways that regulate OS dissemination is requi...

    Authors: Cinzia Zucchini, Maria Cristina Manara, Camilla Cristalli, Marianna Carrabotta, Sara Greco, Rosa Simona Pinca, Cristina Ferrari, Lorena Landuzzi, Michela Pasello, Pier-Luigi Lollini, Marco Gambarotti, Davide Maria Donati and Katia Scotlandi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:503
    Content type: Research Published on:

  38. MKK3 is a member of the dual specificity kinase group specific upstream activator of p38 MAPK proteins. We originally identified MKK3 as mutant p53 (mutp53) gain-of-function (GOF) upregulated target gene in di...

    Authors: Lorenzo Stramucci and Gianluca Bossi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:504
    Content type: Commentary Published on:

  39. Liver cancer stem cells (LCSCs) contribute to hepatocellular carcinoma (HCC) development, metastasis, and drug resistance. MSI2 and Notch1 signaling are involved in the maintenance of CSCs. However, it is unkn...

    Authors: Xiju Wang, Ronghua Wang, Shuya Bai, Si Xiong, Yawen Li, Man Liu, Zhenxiong Zhao, Yun Wang, Yuchong Zhao, Wei Chen, Timothy R. Billiar and Bin Cheng
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:505
    Content type: Research Published on:

  40. Circular RNA nuclear factor I X (circNFIX) has been reported to play an important role in glioma progression. However, the mechanism by which circNFIX participates in glioma progression remains poorly understood.

    Authors: Chenyu Ding, Zanyi Wu, Honghai You, Hongliang Ge, Shufa Zheng, Yuanxiang Lin, Xiyue Wu, Zhangya Lin and Dezhi Kang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:506
    Content type: Research Published on:

  41. Ovarian cancer (OC) is the most lethal gynecological malignancy and the second leading cause of cancer-related death in women. Treatment with PARP inhibitors (PARPi), such as Olaparib, has been recently introd...

    Authors: Enrica Vescarelli, Giulia Gerini, Francesca Megiorni, Eleni Anastasiadou, Paola Pontecorvi, Luciana Solito, Claudia De Vitis, Simona Camero, Claudia Marchetti, Rita Mancini, Pierluigi Benedetti Panici, Carlo Dominici, Ferdinando Romano, Antonio Angeloni, Cinzia Marchese and Simona Ceccarelli
    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:3
    Content type: Research Published on:

  42. MiR-199a-3p (miR-199a) can enhance the chemosensitivity of hepatocellular carcinoma (HCC). Because of the easy degradation of miRNA by direct infusion, effective vehicle-mediated delivery of miR-199a may repre...

    Authors: Guohua Lou, Liang Chen, Caixia Xia, Weina Wang, Jinjin Qi, Aichun Li, Liying Zhao, Zhi Chen, Min Zheng and Yanning Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:4
    Content type: Research Published on:

  43. LncRNA LINC00662 is closely related to the occurrence and development of cancer. This study aims to explore the effect of LINC00662 on colon cancer tumor growth and metastasis and its molecular mechanism.

    Authors: Bo Cheng, Aimei Rong, Quanbo Zhou and Wenlu Li
    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:5
    Content type: Research Published on:

  44. Recent evidence indicates that metformin inhibits mammalian cancer growth and metastasis through the regulation of microRNAs. Metformin regulates miR-381 stability, which plays a vital role in tumor progressio...

    Authors: Dan Jin, Jiwei Guo, Yan Wu, Weiwei Chen, Jing Du, Lijuan Yang, Xiaohong Wang, Kaikai Gong, Juanjuan Dai, Shuang Miao, Xuelin Li and Guoming Su
    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:6
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2022 41:339

  45. Quiescent/slow cycling cells have been identified in several tumors and correlated with therapy resistance. However, the features of chemoresistant populations and the molecular factors linking quiescence to c...

    Authors: Federica Francescangeli, Paola Contavalli, Maria Laura De Angelis, Silvia Careccia, Michele Signore, Tobias Longin Haas, Federico Salaris, Marta Baiocchi, Alessandra Boe, Alessandro Giuliani, Olga Tcheremenskaia, Alfredo Pagliuca, Ombretta Guardiola, Gabriella Minchiotti, Lidia Colace, Antonio Ciardi…
    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:2
    Content type: Research Published on:

  46. Long noncoding RNAs (lncRNAs) are involved in the progression of various cancers and affect the response to radiotherapy. This study focused on clarifying the underlying mechanism by which lncTUG1 affects the ...

    Authors: Pan Wang, Zhuanbo Yang, Ting Ye, Fei Shao, Jiagen Li, Nan Sun and Jie He
    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:7
    Content type: Research Published on:

  47. Low oxygen condition (hypoxia) is considered a hallmark of rapidly growing solid tumors. The presence of hypoxia renders tumor cells resistant to conventional chemo- and radio-therapy, selecting a more maligna...

    Authors: Maria Carla Bosco, Gabriella D’Orazi and Donatella Del Bufalo
    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:8
    Content type: Commentary Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:43

  48. Circular RNAs (circRNAs) have recently emerged as a new family of noncoding RNAs that are involved in the causation and progression of various cancers. However, the roles of circRNAs in the tumorigenesis of ga...

    Authors: Guangxu Deng, Tingyu Mou, Jiayong He, Da Chen, Daojun Lv, Hao Liu, Jiang Yu, Shuang Wang and Guoxin Li
    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:1
    Content type: Research Published on:

  49. Localized C3 deposition is a well-known factor of inflammation. However, its role in oncoprogression of gastric cancer (GC) remains obscured. This study aims to explore the prognostic value of C3 deposition an...

    Authors: Kaitao Yuan, Jinning Ye, Zhenguo Liu, Yufeng Ren, Weiling He, Jianbo Xu, Yulong He and Yujie Yuan
    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:9
    Content type: Research Published on:

  50. In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with ‘DMT1’ now corrected to read ‘DNMT1’.

    Authors: Ssu-Chuan Lai, Yu-Ting Su, Ching-Chi Chi, Yung-Che Kuo, Kam-Fai Lee, Yu-Chih Wu, Pei-Chi Lan, Muh-Hwa Yang, Te-Sheng Chang and Yen-Hua Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:10
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:474

Annual Journal Metrics

  • 2022 Citation Impact
    11.3 - 2-year Impact Factor
    11.5 - 5-year Impact Factor
    1.870 - SNIP (Source Normalized Impact per Paper)
    2.413 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    100 days submission to accept (Median)

    2023 Usage 
    3,003,080 downloads
    3,022 Altmetric mentions

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us